729 related articles for article (PubMed ID: 11593409)
1. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
2. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM
J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005
[TBL] [Abstract][Full Text] [Related]
3. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
[TBL] [Abstract][Full Text] [Related]
4. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
Vogel W; Ullrich A
Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
[TBL] [Abstract][Full Text] [Related]
5. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.
Saxton TM; Henkemeyer M; Gasca S; Shen R; Rossi DJ; Shalaby F; Feng GS; Pawson T
EMBO J; 1997 May; 16(9):2352-64. PubMed ID: 9171349
[TBL] [Abstract][Full Text] [Related]
6. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
[TBL] [Abstract][Full Text] [Related]
8. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation.
Qu CK; Feng GS
Oncogene; 1998 Jul; 17(4):433-9. PubMed ID: 9696036
[TBL] [Abstract][Full Text] [Related]
9. Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.
Kapoor GS; Zhan Y; Johnson GR; O'Rourke DM
Mol Cell Biol; 2004 Jan; 24(2):823-36. PubMed ID: 14701753
[TBL] [Abstract][Full Text] [Related]
10. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
12. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
[TBL] [Abstract][Full Text] [Related]
13. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
14. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1.
Dong Q; Siminovitch KA; Fialkow L; Fukushima T; Downey GP
J Immunol; 1999 Mar; 162(6):3220-30. PubMed ID: 10092773
[TBL] [Abstract][Full Text] [Related]
16. Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cells.
Tenev T; Böhmer SA; Kaufmann R; Frese S; Bittorf T; Beckers T; Böhmer FD
Eur J Cell Biol; 2000 Apr; 79(4):261-71. PubMed ID: 10826494
[TBL] [Abstract][Full Text] [Related]
17. Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells.
Nieborowska-Skorska M; Slupianek A; Skorski T
Oncogene; 2000 Aug; 19(36):4117-24. PubMed ID: 10962572
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
Wheadon H; Edmead C; Welham MJ
Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
[TBL] [Abstract][Full Text] [Related]
19. Localization and down-regulating role of the protein tyrosine phosphatase PTP2C in membrane ruffles of PDGF-stimulated cells.
Cossette LJ; Hoglinger O; Mou L; Shen SH
Exp Cell Res; 1996 Mar; 223(2):459-66. PubMed ID: 8601424
[TBL] [Abstract][Full Text] [Related]
20. Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt.
Hakak Y; Hsu YS; Martin GS
Oncogene; 2000 Jun; 19(28):3164-71. PubMed ID: 10918571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
